25
Participants
Start Date
May 1, 2025
Primary Completion Date
December 1, 2027
Study Completion Date
May 1, 2028
Cryoneurolysis
Each participant will receive cryoneurolysis which involves the application of extreme cold directly to, or near targeted nerves under ultrasound guidance. This cold causes axonotmesis to occur, thereby completely preventing the treated nerve from propagating any signal. Cryoneurolysis produces an effect called Wallerian degeneration, where the treated nerve's axon is destroyed but the epineurium and perineurium are left intact. Therefore, the axon can regenerate, following the same path as prior to treatment.
Parkwood Institute, London
Collaborators (1)
Pacira Pharmaceuticals, Inc
INDUSTRY
Sue Peters
OTHER